Similarly, CD8+ T-cell or macrophage depletion abolished the antitumor activity of AdVAPOA1 (Fig. 8k), suggesting that AdVAPOA1 achieves tumor control by initiating a macrophage–T-cell axis. This evidence concerns the gene CD8A and neoplasm.